In the breast TME, tumor and stromal cells stimulate cytokine-mediated p38MAPK signaling that increases expression of pro-angiogenic and pro-invasive factors such as VEGFA, IL8, IL6, HBEGF, and Fibronectin. Here, HBEGF is linked to neoplasm.